STERIS plc Files 8-K on Financial Results & Operations
Ticker: STE · Form: 8-K · Filed: Feb 7, 2024 · CIK: 1757898
Complexity: simple
Sentiment: neutral
Topics: results-of-operations, financial-condition, corporate-governance, 8-K
TL;DR
**STERIS plc just dropped an 8-K on financial results, time to check the numbers!**
AI Summary
STERIS plc filed an 8-K on February 7, 2024, to report its results of operations and financial condition, along with financial statements and exhibits. This filing confirms the company's current registration details, including its address at 70 Sir John Rogerson's Quay, Dublin 2, Ireland, and its Ordinary Shares trading on an unspecified exchange. This matters to investors as it provides updated official company information and signals the release of financial performance data, which is crucial for evaluating the stock's health and future prospects.
Why It Matters
This filing indicates STERIS plc has released its latest financial performance, which is critical for investors to assess the company's profitability and stability. Understanding these results helps shareholders make informed decisions about buying, holding, or selling the stock.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial results and operational status, not indicating any immediate new risks.
Analyst Insight
A smart investor would review the full financial statements and exhibits referenced in this 8-K to understand STERIS plc's detailed performance and operational health before making any investment decisions.
Key Numbers
- 001-38848 — Commission File Number (Identifies STERIS plc's registration with the SEC)
- 353 1 232 2000 — Registrant's telephone number (Contact information for STERIS plc)
- $0.001 — par value (Par value of STERIS plc's Ordinary Shares)
Key Players & Entities
- STERIS plc (company) — the registrant filing the 8-K
- Dublin 2, Ireland (location) — principal executive offices of STERIS plc
- 001-38848 (number) — Commission File Number for STERIS plc
- February 7, 2024 (date) — Date of earliest event reported and filing date
- $0.001 (dollar_amount) — par value of Ordinary Shares
Forward-Looking Statements
- STERIS plc will likely hold an earnings call or investor presentation soon to discuss the reported financial results. (STERIS plc) — high confidence, target: Q1 2024
- Analysts will update their price targets and ratings for STERIS plc based on the detailed financial information provided in the full filing. (STERIS plc) — high confidence, target: Within 2 weeks of filing
FAQ
What is the primary purpose of this 8-K filing by STERIS plc?
The primary purpose of this 8-K filing by STERIS plc, dated February 7, 2024, is to report on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' as per Item Information.
What is the exact name and address of the registrant as specified in the charter?
The exact name of the registrant is STERIS plc, and its address is 70 Sir John Rogerson's Quay, Dublin 2, Ireland D02 R296.
What is the par value of STERIS plc's Ordinary Shares?
The par value of STERIS plc's Ordinary Shares is $0.001, as stated under 'Title of each class' in the 'Securities registered pursuant to Section 12(b) of the Act' section.
What is the Commission File Number for STERIS plc?
The Commission File Number for STERIS plc is 001-38848, as indicated in the filing.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 7, 2024, which is also the date of the report.
Filing Stats: 567 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-02-07 16:38:06
Key Financial Figures
- $0.001 — e on which registered Ordinary Shares, $0.001 par value STE New York Stock Exchange
Filing Documents
- ste-20240207.htm (8-K) — 37KB
- ste12312023ex991.htm (EX-99.1) — 529KB
- 0001757898-24-000001.txt ( ) — 769KB
- ste-20240207.xsd (EX-101.SCH) — 3KB
- ste-20240207_def.xml (EX-101.DEF) — 7KB
- ste-20240207_lab.xml (EX-101.LAB) — 31KB
- ste-20240207_pre.xml (EX-101.PRE) — 18KB
- ste-20240207_htm.xml (XML) — 6KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 7, 2024, STERIS plc (the "Company") issued a press release announcing financial results for its fiscal 2024 third quarter ending December 31, 2023. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. Furthermore, the information contained in this Item 2.02 of this Current Report on Form 8-K shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press Release issued by STERIS plc on February 7, 202 4 announcing financial results for its fiscal 2024 third quarter ending December 3 1 , 2023. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STERIS plc By /s/ J. Adam Zangerle Name: J. Adam Zangerle Title: Senior Vice President, General Counsel & Company Secretary Dated: February 7, 2024